Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implications, including an opportunity to understand mechanisms behind relapses and drug resistance. Next generation bulk sequencing is a mature tech- nology that has been used to study subclonal tumour populations at an aggregate level. Inference of populations from bulk sequencing requires sophisticated com- putational deconvolution methods. An alternative is to identify populations directly with single cell sequencing. However, single cell sequencing is a very error-prone process, and this impedes its ability to completely replace bulk sequencing for now. In this work we present dd-PyClone, a statistical model to combine single cell and bulk seque...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Motivation: Several cancer types consist of multiple genetically and phenotypically distinct subpopu...
Next-generation sequencing (NGS) of bulk tumour tissue can identify constituent cell populations in ...
Background: At diagnosis tumours are typically composed of a mixture of genomically...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
Abstract Background High-throughput sequencing allows...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary dynami...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Background: The large-scale availability of whole-genome sequencing profiles from bulk DNA sequencin...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Motivation: Several cancer types consist of multiple genetically and phenotypically distinct subpopu...
Next-generation sequencing (NGS) of bulk tumour tissue can identify constituent cell populations in ...
Background: At diagnosis tumours are typically composed of a mixture of genomically...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
Abstract Background High-throughput sequencing allows...
Traditional classifications and treatment of human cancers have operated with limitations surroundin...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary dynami...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Background: The large-scale availability of whole-genome sequencing profiles from bulk DNA sequencin...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Motivation: Several cancer types consist of multiple genetically and phenotypically distinct subpopu...